Showing 2731-2740 of 4166 results for "".
- EyeSouth Partners Unveils Clinical Research Divisionhttps://modernod.com/news/eyesouth-partners-unveils-clinical-research-division/2482345/EyeSouth Partners has announced the expansion of
- Aurion Biotech to Present Clinical Data at ASCRShttps://modernod.com/news/aurion-biotech-to-present-clinical-data-at-ascrs/2482204/Aurion Biotech announced several presentations during the 2024 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting to be held April 5-8, 2024 in Boston. At Eyecelerator and ASCRS, data will be presented from the company’s Escal&
- Oxurion Provides Update on Clinical Pipeline Progresshttps://modernod.com/news/oxurion-provides-update-on-clinical-pipeline-progress/2480551/
- EyeD Lands $51M to Take Glaucoma Implant Into the Clinichttps://modernod.com/news/eyed-lands-51m-to-take-glaucoma-implant-into-the-clinic/2480544/EyeD Pharma’s new spin on an old molecule has attracted investor support, giving it 45 million euros ($51 million) to advance an implant that could challenge AbbVie for the glaucoma mar
- As Ophthalmology Clinics Reopen, New Questions Aboundhttps://modernod.com/news/as-ophthalmology-clinics-reopen-new-questions-abound/2478093/As the COVID-19 pandemic continues to upend our professional and personal lives, predicting what the future may hold has become an increasingly difficult task. Sumit (Sam) Garg, MD, wrote a commentary for Medscape News discussing what the
- ImprimisRx: Clinical Study Examines Combination Prescription Eyedropshttps://modernod.com/news/imprimisrx-clinical-study-examines-combination-prescription-eyedrops/2478002/ImprimisRx announced the findings from a randomized contralateral eye study comparing patient outcomes and preferences for a combination therapy with individual eye drop medications after ocular surgery. The prospective study,
- In-Clinic Hurdles for AI-Based Diabetic Retinopathy Detectionhttps://modernod.com/news/in-clinic-hurdles-for-ai-based-diabetic-retinopathy-detection/2479810/Researchers found mixed results when they tested an artificial intelligence (AI)‒based system for detecting diabetic retinopathy (DR) in a real-world primary care setting in Midland, Australia, according to a Medscape report. In th
- Topical Presbyopia Treatment Advances in Clinical Developmenthttps://modernod.com/news/presbyopia-therapies-announces-primary-safety-and-efficacy-resutls-in-phase-2b-study-of-topical-presbyopia-treatment/2479978/Presbyopia Therapies announced that the primary efficacy and safety endpoints have been met in a phase 2b study of its PRX ophthalmic solution. PRX demonstrated a 3 line or greater improvement in monocular distance corrected near acuity in patients between the ages of 48 and 64, with this improve
- Euclid and Visionary Optics Announce Interactive Specialty Lens Forums in Cities Across the UShttps://modernod.com/news/euclid-and-visionary-optics-announce-interactive-specialty-lens-forums-in-cities-across-the-us/2481620/Euclid Vision is joining forces with Visionary Optics to host multiple specialty contact lens dinner discussions in cities around the US. The program,
- Wichita Optometry Expands Services With the Purchase of Two Practiceshttps://modernod.com/news/wichita-optometry-expands-services-with-the-purchase-of-two-practices/2480105/Wichita Optometry has announce the expansion of its service area with the purchase of two additional optometry practices: Mulvane Vision Care and Wichita Vision Care. Mulvane Vision Care is located at 415 S.E. Louis Blvd. in Mulvane, Kansas and Wichita Vision Care is located at 12111 W. Maple St.